Biogen (BIIB) Appoints Sean Godbout as Chief Accounting Officer & Global Corporate Controller

On January 13, 2025, Biogen (NASDAQ: BIIB) appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated Mr. Godbout as the Company’s principal accounting officer, in each case effective as of March 1, 2025. In connection with Mr. Godbout’s appointment as Chief Accounting Officer, Robin Kramer, the Company’s current Chief Accounting Officer, will no longer be designated as the Company’s principal accounting officer as of the effective date of Mr. Godbout’s appointment. As previously announced, Ms. Kramer has been appointed the Company’s Chief Financial Officer, effective upon the retirement of Michael McDonnell, the Company’s current Chief Financial Officer. Mr. McDonnell will retire on March 1, 2025.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Kimbell Royalty closes $221.2M mineral rights acquisition
• Silexion Therapeutics faces Nasdaq delisting over equity shortfall